Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.9K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

380
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
380
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

339
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
339
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.5K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.5K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

602
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
602

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Metrics Replace Values: Ethical Concerns in Healthcare Performance Measures.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2026
Same author

The authors respond to reader comment regarding machine learning models to detect opioid misuse in emergency department patients at triage.

The American journal of emergency medicine·2026
Same author

Responsiveness of the 2024-2030 ACMT Research Agenda to New Funding Priorities and Research Environment.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same author

Development and evaluation of machine learning models for the detection of emergency department patients with opioid misuse from clinical notes.

JAMIA open·2026
Same author

Machine learning models to detect opioid misuse in emergency department patients at triage.

The American journal of emergency medicine·2026
Same author

The National Poison data System<sup>®</sup>: a bibliographic review of publication trends and topic modeling using language models.

Clinical toxicology (Philadelphia, Pa.)·2025

Related Experiment Video

Updated: Apr 11, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.3K

Digoxin-Specific Antibody Fragment Dosing: A Case Series.

Neeraj Chhabra1, Matthew Valento, Sean M Bryant

  • 11Department of Emergency Medicine, Cook County Health and Hospitals System, Chicago, IL; 2Division of Emergency Medicine, University of Washington, Seattle, WA; 3The Illinois Poison Center, Chicago, IL; and 4The Toxikon Consortium, Chicago, IL.

American Journal of Therapeutics
|June 10, 2015
PubMed
Summary

Digoxin-specific antibody fragments (DSFab) dosing for digoxin poisoning may be overestimated by current empiric regimens. This study found average DSFab doses were lower than typically recommended for both chronic and acute cases.

More Related Videos

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

2.5K
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.5K

Related Experiment Videos

Last Updated: Apr 11, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.3K
Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

2.5K
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.5K

Area of Science:

  • Toxicology
  • Pharmacology
  • Clinical Medicine

Background:

  • Digoxin-specific antibody fragments (DSFab) are crucial for treating cardiac glycoside poisoning.
  • Current DSFab dosing relies on steady-state serum concentrations, historical data, or empiric regimens.
  • Empiric dosing often suggests 3-6 vials for chronic and 10-20 vials for acute digoxin poisoning.

Purpose of the Study:

  • To determine average DSFab dosing requirements based on serum concentrations or historical data.
  • To compare actual DSFab requirements with established empiric dosing regimens.
  • To evaluate potential overestimation in current digoxin poisoning treatment protocols.

Main Methods:

  • Retrospective analysis of 11-year data from the Illinois Poison Center.
  • Inclusion of 140 chronic and 26 acute digoxin poisoning cases requiring DSFab.
  • Calculation of average recommended DSFab doses from case data.

Main Results:

  • Average DSFab dose for chronic digoxin poisoning was 3.05 vials (SD ± 1.31).
  • Average DSFab dose for acute digoxin poisoning was 6.33 vials (SD ± 5.26).
  • These findings indicate actual needs are often lower than empiric recommendations.

Conclusions:

  • Empiric dosing regimens for DSFab in digoxin poisoning may frequently overestimate the required amount.
  • Revised dosing guidelines could optimize DSFab utilization and potentially reduce healthcare costs.
  • Further research into refined dosing strategies for digoxin toxicity is warranted.